A study evaluates the feasibility and clinical utility of integrating routine, electronic patient-reported outcome screening into a dedicated thyroid cancer survivorship clinic to monitor long-term ...
Emergency presentation (EP) for cancer diagnosis is common among older U.S. adults and predicts persistently elevated mortality, according to a study published ...
Researchers investigated inotuzumab ozogamicin for children with CD22-positive, very high-risk first B-cell acute lymphoblastic leukemia relapse.
Investigators evaluated the relationship between overall survival and discontinuing immune checkpoint inhibitor therapy due to immunological toxicity in patients with metastatic melanoma.
Remote patient-reported outcome (PRO) monitoring may improve cancer care for underserved patients, according to a study recently published in JCO Oncology Practice. Allison M. Deal, from the ...
A new model, based on factors identified via machine learning, predicts overall survival at 1, 3, and 5 years after nephrectomy for nonmetastatic renal cell carcinoma (RCC). A separate study suggests ...
A systematic review and meta-analysis compared clinical and patient-reported outcomes between subcapsular and total orchiectomy in patients with advanced prostate cancer.
Researchers investigate the potential relationship between digital health engagement and psychological distress among US adults using cross-sectional survey data.
A secondary analysis of the DIPLOMA-2 trial evaluates differences in early physical activity and physiologic stress recovery between patients undergoing minimally invasive vs open ...
Researchers developed the Advocacy-Adjustment Dyad, a new clinical framework designed to foster therapeutic partnerships between nurses and older adults with cancer in the intensive care unit.
The index provides additional prognostic separation beyond Memorial Sloan Kettering Cancer Center risk categories and established clinical factors.
This multicenter study identifies key clinical and sociodemographic factors associated with fear of cancer recurrence in breast cancer survivors.